JCMS Header


Contents, JCMS, Vol. 3(2), Supplement


Atopic Dermatitis: Introduction and Overview
Seth R. Stevens, Kefei Kang, and Kevin D. Cooper
S2-2

Atopic Dermatitis: The Spectrum of Disease
Vincent S. Beltrani
S2–8

Treatment of Atopic Dermatitis
Bernice R. Krafchik
S2–16

The Role of Food and Inhaled Allergens in Atopic Dermatitis
Eyal Grunebaum and Sasson Lavi
S2–24

The Role of Infection in Atopic Dermatitis
Amin S. Kanani and Gordon L. Sussman
S2–29

Editorial


Atopic dermatitis is a common dermatosis with a relapsing course. While the pathogenesis is still unknown, significant evidence has accumulated regarding the role of Langerhans cells and Th2 cytokines in the pathogenesis. In this supplement, we have an excellent overview by one of the major leaders in this field, Dr. Kevin Cooper, who acted as guest editor of this issue, and his associates, Drs. Stevens and Kang. Dr. Beltrani reviews the clinical spectrum of disease including the diagnostic criteria for establishing a diagnosis. Dr. Krafchik reviews the therapeutic options including standard therapy as well as new, more innovative treatments. Individuals with atopic dermatitis have an increased susceptibility to infection and colonization by bacteria, fungi, and viruses. These agents not only complicate the disease, but may play a role in exacerbation of the disease. Drs. Kanani and Sussman review the role of infections in atopic dermatitis. It has long been known that inhaled allergens can be associated with an exacerbation of atopy. More recently, there has been increasing evidence to suggest the prevalence of food allergens may also play a role in certain individuals. Drs. Lavi and Grunebaum examine the part played by inhalant and food allergens in atopic dermatitis, emphasizing primary, secondary, and tertiary prevention of the disease. This volume will serve as a concise review of current understanding of atopic dermatitis.

Daniel N. Sauder
Editor-in-Chief


JCMS Homepage